Noctrix Health is pioneering the development of wearable therapeutics specifically designed to address chronic neurological disorders, with a focus on Restless Legs Syndrome (RLS). Their flagship product, the Tonic Motor Activation (TOMAC) therapy, is a clinically validated, drug-free wearable device that has been shown to effectively reduce the symptoms associated with RLS. This innovative approach offers a significant alternative to traditional pharmaceutical treatments, which often leave patients with unresolved symptoms despite ongoing medication. The company emphasizes the importance of providing effective solutions for the millions of Americans affected by RLS, a condition that disrupts sleep and can lead to significant discomfort.

The technology behind Noctrix Health's wearable therapy has garnered attention through successful clinical trials, including randomized controlled trials that have demonstrated its efficacy. The device has received FDA marketing authorization, highlighting its potential as a breakthrough treatment option. By focusing on non-pharmaceutical interventions, Noctrix Health aims to improve the quality of life for individuals suffering from RLS, addressing a critical unmet need in the management of this prevalent sleep disorder.

United States

Their vision is to develop clinically validated ‘therapeutic wearables’ that allow for medical devices to become a true alternative to pharmaceuticals in the management of chronic neurological disorders.

Noctrix Health

Company Details